Furthermore, data from the UALCAN database demonstrated that the HMGN1 protein was over-expressed in the malignant colon, breast, glioblastoma multiforme, LIHC, LUAD, and ovarian cancer tissues compared to the healthy tissue samples. This evidence concerns the gene HMGN1 and ovarian carcinoma.